-
Kenya Is the First Country to Receive $1 Medications for Chronic Illnesses
A global pharmaceutical company is taking the lead in the fight against chronic illnesses by offering treatment at extremely low costs.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Harvard Leadership Programme Helps Baby-Boomer Bosses to Save the World
About a year and a half ago, Ken Kelley, the founder of Paxvax, a vaccine company which focuses on the travel industry, became afflicted with what he calls an “intellectual itch”. He wondered why certain diseases, such as Ebola and dengue fever, lack vaccine protection.
- Categories
- Environment, Health Care
-
World’s First Dengue Vaccine Approved After 20 Years of Research
The first vaccine against dengue fever won clearance in Mexico, an initial step toward preventing a mosquito-borne infection that puts half of the world’s population at risk.
- Categories
- Health Care
- Region
- Latin America
-
S. African Health Activists Protest Sanofi Over Lack of BCG Vaccine
Sanofi ($SNY) continues to come under pressure from health groups who say the drugmaker has ceased manufacturing the BCG vaccine and created a global shortage of the jab used to treat tuberculosis and bladder cancer.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Vaxess Co-Founder Wants to ‘Play a Role in the Eradication of Polio’
It's a rarity that an idea borne out of a classroom has the ability to take shape in such a powerful way -- but the team at Vaxess Technologies has come closer than many.
- Categories
- Health Care
-
Sanofi’s Unveils Made in India Injectable Polio Vaccine
Sanofi Pasteur, the vaccines division of Sanofi, has unveiled ShanIPV, an injectable inactivated polio vaccine (IPV) manufactured by its affiliate Shantha Biotechnics, Hyderabad.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
The Ebola Vaccine, Latrogenic Injuries, and Legal Liability
Making vaccines is a risky, oftentimes unenviable business. Vaccines are administered to healthy people who tend to be unforgiving if an adverse side effect or injury subsequently develops. The risk of being sued, even when a vaccine supplier follows best practices, combined with growing anti-vaccination sentiment, creates a climate that is not conducive to vaccine innovation. The dissuasive effect of litigation risk and legal liability is heightened both for vaccines aimed at diseases of poor countries, for which the financial inducements are weak anyway [1,2], and vaccines for public health emergencies, which are developed in accelerated clinical trials that may lack the statistical power or detailed follow-up necessary to detect rare adverse effects. Yet, as the West African Ebola outbreak demonstrates, the world can ill afford not to have vaccines against diseases of poverty in emergency situations [1]. Several reasons exist for not having a vaccine available, relating to the biology of the virus and the epidemiological challenges pertaining to evaluating a vaccine for a rare disease. However, financial incentives and disincentives for vaccine manufactures to invest in vaccine trials for rare diseases in resource-poor countries also need to be considered. We argue that, as one part of a comprehensive plan to promote vaccine development, there needs to be a plan to lessen the risks of litigation and liability to remove disincentives for these vaccines to be developed and later deployed. As others point out, no satisfactory plan now exists [3].
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Can This Necklace Help More Kids Get Vaccinated?
It looks like a normal necklace. Just a small, clear plastic droplet dangling from a thick black thread.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines